Sustained Responses and Loss of HBsAg in HBeAg-Negative Patients With Chronic Hepatitis B Who Stop Long-Term Treatment With Adefovir
- 1 September 2012
- journal article
- research article
- Published by Elsevier BV in Gastroenterology
- Vol. 143 (3), 629-636.e1
- https://doi.org/10.1053/j.gastro.2012.05.039
Abstract
No abstract availableKeywords
Funding Information
- National and Kapodistrian University of Athens
- Gilead Sciences
This publication has 29 references indexed in Scilit:
- Does Antiviral Therapy Prevent Hepatocellular Carcinoma?Antiviral Therapy, 2011
- The Natural History of Chronic HBV Infection and Geographical DifferencesAntiviral Therapy, 2010
- Relapse of hepatitis B in HBeAg-negative chronic hepatitis B patients who discontinued successful entecavir treatment: The case for continuous antiviral therapyJournal of Hepatology, 2009
- Hepatitis B virus surface antigen levels: A guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis BHepatology, 2008
- EASL Clinical Practice Guidelines: Management of chronic hepatitis BJournal of Hepatology, 2008
- Management of hepatitis B: Summary of a clinical research workshopHepatology, 2007
- Long-term Therapy With Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B for up to 5 YearsGastroenterology, 2006
- HBeAg-negative chronic hepatitis B: From obscurity to prominenceJournal of Hepatology, 2006
- Sustained response after a 2‐year course of lamivudine treatment of hepatitis B e antigen‐negative chronic hepatitis BJournal of Viral Hepatitis, 2004
- The long-term outcome of interferon-α treated and untreated patients with HBeAg-negative chronic hepatitis BJournal of Hepatology, 2001